Diagnostic imaging company Diagnostic Healthcare has secured GBP1m investment from The North West Fund for Biomedical, managed by SPARK Impact.
Diagnostic Healthcare, headquartered in Altrincham, has a network of centres and mobile units across the UK providing MRI scans, obstetric ultrasound, bone density scans (DEXA scan), cardiac testing, health screening and reporting services.
The company offers end-to-end integrated solutions, either as mobile services or located within hospitals, GP surgeries or dedicated community sites.
The North West Fund for Biomedical is part of the wider GBP155m North West Fund, financed jointly by the European Regional Development Fund and the European Investment Bank.
The funding will be used by Diagnostic Healthcare to help it expand its diagnostic services, increase community services in more locations across the country and expand its portfolio of medical equipment.
Diagnostic Healthcare, which has provided diagnostic services in the UK and abroad for 20 years, supports the NHS and the private market in the provision of scanning and reporting, ensuring best value for money, efficiency and best patient care.
Liat Karni, managing director of Diagnostic Healthcare, says: “This investment will support the on-going growth of the company and will enable us to provide more high-end diagnostic services in more locations across the UK, as well as expanding our leading range of medical equipment.”
Penny Attridge, senior investment director at SPARK Impact and manager of The North West Fund for Biomedical, says: “The range of services being provided by Diagnostic Healthcare could make a significant impact on the provision of diagnostic imaging in the UK and abroad. We are delighted to make this investment in a high quality service which is an asset to the North West and to SPARK’s biomedical portfolio.”
Diagnostic Healthcare is The North West Fund for Biomedical’s 34th investment to date.
